RxDoctor Payments Data

Jason Beasley, MD

Family Medicine · Collins, MSNPI 1508860214

Payments from drug & device makers

$1,045in general payments, 2019–2025

Across 56 payments — averaging $18.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$229
  • Pfizer$228
  • Novo Nordisk$137
  • Amgen$109
  • Boehringer Ingelheim$71
  • Lilly USA, LLC$54
  • plus $216 from 8 others

What the payments were for

  • Food & beverage$1,045100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,045 in reported general payments places this provider in the 60th percentile of 971 family medicine providers in Mississippi.

See all family medicine providers in Mississippi

Medicare billing

Part B allowed, 2024
$49,203
Medicare patients
97
Services billed
1,375

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide48$51,917
EliquisApixaban62$40,145
FarxigaDapagliflozin Propanediol47$30,025
XareltoRivaroxaban36$18,991
Breztri AerosphereBudesonide/Glycopyr/Formoterol13$16,791
Janumet XrSitagliptin Phos/Metformin Hcl27$16,786
Trijardy XrEmpaglifloz/Linaglip/Metformin23$16,192
Repatha SureclickEvolocumab20$15,532
MyrbetriqMirabegron30$13,397
Bydureon BciseExenatide Microspheres11$13,393
Tresiba Flextouch U-200Insulin Degludec12$13,195
Dexlansoprazole DrDexlansoprazole51$13,122
Synjardy XrEmpagliflozin/Metformin Hcl16$11,811
Praluent PenAlirocumab15$10,259
JanuviaSitagliptin Phosphate16$9,675

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$137$51,91748 claims
AstraZenecaFarxiga, Breztri Aerosphere$229$46,81760 claims
PfizerEliquis$228$40,14562 claims
Boehringer IngelheimTrijardy Xr, Synjardy Xr, Tradjenta$71$33,93051 claims
Johnson & JohnsonXarelto, Invokana$14$25,74648 claims
GSKAnoro Ellipta, Trelegy Ellipta, Shingrix$32$19,60347 claims
AbbVieSynthroid$14$3,19956 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 971 family medicine providers in Mississippi.

Other family medicine in Collins

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →